Séminaire BioCIS : "XCE853 : Inhibitor of Protein disulfide Isomerase against cancer" - Université Paris-Sud - Faculté de Pharmacie

Séminaire BioCIS : "XCE853 : Inhibitor of Protein disulfide Isomerase against cancer"

Dr Grégoire Prevost (CIPREVO, Antony)

Université Paris-Sud - Faculté de Pharmacie - Salle des thèses

CIPREVO is a new service company providing expertise on cancer research and development projects to clients such Pharmas, Biotechs, Start-ups,Consortiums, Investors, Funds, Academic groups or Patient associations.

https://www.ciprevo-cancer.com/